Cancer Center– A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Neoplasms, Germ Cell and Embryonal"

Drug Intervention Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
A Study of Pemetrexed in Children With Recurrent Cancer Dr. Neyssa Maria Marina
 Osteosarcoma
Neuroblastoma
Medulloblastoma
An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome George Albert Fisher M.D. Ph.D.
 Carcinoid Tumor
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Solar Melanoma That Cannot Be Removed By Surgery Harlan Pinto
Sunil Arani Reddy
 Melanoma
Phase 2 of Azixa™ (MPC-6827) for Glioblastoma Multiforme in First or Second Relapse Dr Lawrence Recht
 Brain Cancer
Glioblastoma
BIBW 2992 With or Without Daily Temozolomide For Recurrent Malignant Glioma Dr Lawrence Recht
 Oligodendroglioma
Glioma
Glioblastoma
Phase 3 Efficacy Study of XL184 in Adults With Medullary Thyroid Cancer Dr. A. Dimitrios Colevas
 Neuroendocrine Tumors
Thyroid Cancer
Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma Paul Graham Fisher
 Central Nervous System Neoplasms
Brain Cancer
Neuroectodermal Tumors
Medulloblastoma
Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma Dr. Neyssa Marina
 Neuroblastoma
Melphalan and Buthionine Sulfoximine Followed by Stem Cell Transplantation in Children With Resistant or Recurrent Neuroblastoma Clare J. Twist M.D.
 Neuroblastoma
Ph III Randomized Study of Four Weeks of High-Dose IFN-á2b for Microscopic Melanoma Harlan Pinto
 Melanoma
Skin Cancers
Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors George Albert Fisher M.D. Ph.D.
 Neuroendocrine Tumors
Iodine I 131 Metaiodobenzylguanidine, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell or Bone Marrow Transplant for Relapsed or Refractory Neuroblastoma Clare J. Twist M.D.
 Neuroblastoma
Ixabepilone in Treating Young Patients With Refractory Solid Tumors Dr. Neyssa Marina
 Sarcoma
Wilms Tumor
Neuroblastoma
SARC 009: A Phase II Trial of Dasatinib in Advanced Sarcomas Kristen N. Ganjoo
 Hemangiopericytoma
Nerve Sheath Neoplasms
Rhabdomyosarcoma
Chordoma
Irinotecan and Vincristine for Radiosensitization of 131I-MIBG Therapy for High-Risk Neuroblastoma Clare J. Twist M.D.
 Neuroblastoma
Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma Clare J. Twist M.D.
 Neuroblastoma
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors Dr. Neyssa Marina
 Ovarian Cancer
Neoplasms, Germ Cell and Embryonal
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma Dr. Neyssa Marina
 Neuroblastoma
Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma Susan M. Swetter
 Melanoma
Dysplastic Nevus Syndrome


Other Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Study of Late-Occurring Complications in Childhood Cancer Survivors Dr. Neyssa Marina
 Leukemia
Sarcoma
Retinoblastoma
Lymphoma
Retinal Neoplasms
Second Curettage in Treating Patients With Persistent Non-Metastatic Gestational Trophoblastic Tumor Amreen Husain
 Gestational Trophoblastic Neoplasms

Trials not Recruiting

Study Title
 Principal Investigator Disease Category
Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement
(No longer recruiting) 		Clare J. Twist M.D.
 Neuroblastoma
Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia
(No longer recruiting) 		Dr. Neyssa Marina
 Leukemia
Lymphoma
Neuroblastoma
Medulloblastoma
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
(No longer recruiting) 		Dr. Neyssa Marina
 Central Nervous System Neoplasms
Brain Cancer
Glioma
hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
(Completed) 		Dr. Neyssa Marina
 Neuroblastoma
Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
(Completed) 		Harlan Pinto
 Melanoma
Skin Cancers
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
(No longer recruiting) 		Dr. Neyssa Marina
 Central Nervous System Neoplasms
Neoplasms, Germ Cell and Embryonal
Brain Cancer
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
(No longer recruiting) 		Dr. Neyssa Marina
 Central Nervous System Neoplasms
Ependymoma
Brain Cancer
Assessing the suitability of an imaging probe for use in clinical cell and gene therapy trials in cancer and rheumatoid arthritis
(No longer recruiting) 		Sanjiv Sam Gambhir M.D., Ph.D.
 Central Nervous System Neoplasms
Brain Cancer
Glioma
Arthritis, Rheumatoid
Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer
(Completed) 		Heather A. Wakelee
 Carcinoma, Small Cell
Phase II/III Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III)
(No longer recruiting) 		Dr Lawrence Recht
 Central Nervous System Neoplasms
Brain Cancer
Glioblastoma
Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma
(No longer recruiting) 		Harlan Pinto
 Melanoma
Skin Cancers


The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: